Michelle M Kittleson
Overview
Explore the profile of Michelle M Kittleson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
218
Citations
4370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuji M, Patel J, Kittleson M, Chang D, Kransdorf E, Nikolova A, et al.
Clin Transplant
. 2025 Mar;
39(3):e70124.
PMID: 40038060
Background: Heart re-transplantation (re-HT) is the last treatment option for end-stage graft failure, with cases due to severe cardiac allograft vasculopathy (CAV) showing a better prognosis compared to other indications....
2.
Dunlay S, Pinney S, Lala A, Stewart G, McIlvennan C, Wong R, et al.
JAMA Cardiol
. 2025 Feb;
PMID: 39908057
Importance: The advanced ambulatory heart failure (HF) population comprises patients who have progressed beyond the pillars of recommended stage C HF therapies but can still find meaningful life-years ahead. Although...
3.
Kransdorf E, Kittleson M
JACC Heart Fail
. 2025 Jan;
13(1):131-132.
PMID: 39779177
No abstract available.
4.
Greenberg G, Onuegbu C, Espiche C, Scotti A, Ippolito P, Dwaah H, et al.
J Card Fail
. 2024 Dec;
PMID: 39701370
Background: Two diagnostic clinical scoring systems, the ATTR-CM Score and the T-AMYLO Score, have been proposed but not validated in diverse populations despite Black race being an important risk factor...
5.
Chikwe J, Kittleson M
N Engl J Med
. 2024 Nov;
391(19):1850-1851.
PMID: 39536233
No abstract available.
6.
Kittleson M
Trends Cardiovasc Med
. 2024 Oct;
PMID: 39442740
Optimal guideline-directed medical therapy for heart failure with reduced ejection fraction comprises the angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan), an evidence-based beta-blocker (bisoprolol, carvedilol, or sustained-release metoprolol), a mineralocorticoid antagonist (spironolactone or...
7.
Bloom M, Vo J, Rodgers J, Ferrari A, Nohria A, Deswal A, et al.
J Card Fail
. 2024 Oct;
31(2):415-455.
PMID: 39419165
Heart failure and cancer remain 2 of the leading causes of morbidity and mortality, and the 2 disease entities are linked in a complex manner. Patients with cancer are at...
8.
Bloom M, Vo J, Rodgers J, Ferrari A, Nohria A, Deswal A, et al.
J Card Fail
. 2024 Oct;
31(2):456-463.
PMID: 39414560
No abstract available.
9.
Tsuji M, Patel J, Kittleson M, Chang D, Kransdorf E, Nikolova A, et al.
J Heart Lung Transplant
. 2024 Oct;
44(1):57-63.
PMID: 39369967
Background: Microvascular dysfunction after heart transplantation leads to restrictive cardiac allograft physiology (RCP), which is classified as severe coronary allograft vasculopathy (CAV); however, the prognosis of RCP remains unclear. Therefore,...
10.